ZOLPIDEM TARTRATE
| Brand name | ZOLPIMIST |
|---|---|
| Active ingredient | ZOLPIDEM TARTRATE |
| Strength | 5MG/SPRAY |
| Dosage form | SPRAY, METERED |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2008 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8236285 | August 2032 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.